Peter P. Pfreundschuh, Chief Financial Officer at UroGen Pharma Ltd. (URGN), sold 2,400 shares at $21.72 ($52K) on 2020-10-15, disclosed to the SEC on 2020-10-16.
Open-market sale of $52k URGN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.72 | 1,017 | $22K | 42.3% |
| 2 | $21.80 | 976 | $21K | 40.7% |
| 3 | $21.82 | 407 | $9K | 17.0% |
| Total | $21.77 avg | 2,400 | $52K | 100% |
| Filing → |
| FREQ | SELL | 2022-02-23 | $11K | — | Filing → |
| FREQ | SELL | 2022-02-18 | $11K | — | Filing → |
| FREQ | SELL | 2022-02-16 | $6K | — | Filing → |